Obaid connects companies with a problem with the specialists who solve it, before either side finds the other on their own.
Independent. Building this lane in the open, 2026–.
Public data across a few different markets: something just changed for these companies, and that's the trigger I watch for.
- →Five peptide and supplement makers hit with FDA warning letters this month for marketing unapproved GLP-1 drugs
- →Oracle cut roughly 30,000 roles this month, the largest single layoff event of 2026 so far
- →7,400+ new consumer brands filed U.S. trademarks last week alone
- →35 open state and local government bids this week call for video production or livestreaming services
Sourced from FDA warning letters (fda.gov), BLS and company layoff reporting, USPTO trademark filings, and BidNet Direct open solicitations.
No deal to point at yet, so here's exactly what I put in motion.
Company with a problem → the specialist who fixes it
You tell me what isn't working and what you've already tried. I bring one match, not a list, and only send someone who actually fits.
Specialist with capacity → the companies who need them
If you do the work, I bring you the companies that just found out they need it, while the need is still fresh.
Building in the open. I’m working alongside myoProcess, a vetted B2B partner trusted across $1B+ in transactions, while I route my first introductions in this lane. My first closed match replaces this paragraph.
What I see in this market that outsiders miss.